RSS   Newsletter   Contact   Advertise with us

Coronavirus vaccine will be ready by early 2021, says SinoVac

Christian Fernsby ▼ | September 25, 2020
SinoVac said Thursday the coronavirus vaccine it is developing should be ready by early 2021 for distribution worldwide.
SinoVac
Coronavirus vaccine   SinoVac
Yin Weidong, the CEO of SinoVac, said he personally has been given the experimental vaccine.

Topics: SinoVac

“At the very beginning, our strategy was designed for China and for Wuhan. Soon after that in June and July we adjusted our strategy, that is to face the world,” Yin said, referring to the Chinese city where the virus first emerged.

“Our goal is to provide the vaccine to the world including the U.S., EU and others,” Yin said.

Stringent regulations in the U.S., European Union, Japan and Australia have historically blocked the sale of Chinese vaccines. But Yin said that could change.

More than 24,000 people are participating in clinical trials of CoronaVac in Brazil, Turkey, and Indonesia, with additional trials scheduled for Bangladesh and possibly Chile, Yin said. SinoVac chose those countries because they all had serious outbreaks, large populations and limited research and development capacity, he said.

He spoke to reporters during a tour of a SinoVac plant south of Beijing. Built in a few months from scratch, the plant is designed to enable SinoVac to produce half a million vaccine doses a year. The bio-secure facility was already busy on Thursday filling tiny bottles with the vaccine and boxing them. The company projects it will be able to produce a few hundred million doses of the vaccine by February or March of next year.

SinoVac is also starting to test small doses of CoronaVac on children and the elderly in China after noticing rising numbers of cases globally among those two groups.

Yin said the company would prioritize distribution of the vaccine to countries hosting human trials of CoronaVac.


 

MORE INSIDE POST